Delivery of Respimat Soft Mist inhaler (SMI) from a Valved Holding Chamber (VHC)
Conclusions: The small differences in FPM between the SMI and SMI+ VHC were within the typical magnitude of method variability. Healthcare providers can have assurance that the use of the SMI with AC+FV VHC should deliver a similar FPM of API compared to the SMI alone.C
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Kushnarev, V., Nagel, M., Doyle, C., Suggett, J. Tags: Airway Pharmacology and Treatment Source Type: research
More News: Canada Health | Combivent | Drugs & Pharmacology | Geriatrics | Laboratory Medicine | Pediatrics | Respiratory Medicine | Spiriva | Tiotropium